Driving ROI: The Business Case for a Comprehensive Clinical Data and Analytics Solution
White Papers
AI Has Exposed a Big Problem in Clinical Data Management. Here’s How to Solve It.
A challenge that has become increasingly familiar for many organizations conducting clinical trials:
Your company invests in advanced analytics or AI-enabled technologies with the expectation that this will lead to faster insights, more proactive decision-making, and greater operational efficiency. Instead, the quality of the outputs is questionable, and teams spend hours backtracking through data to validate these insights and/or figure out where the technology went wrong.
Though your analytics/AI technology seems the most likely culprit, the problem isn’t usually with the latest system. Organizations are instead discovering issues with the underlying data infrastructure supporting these systems.
AI and advanced analytics depend on data that is harmonized, interoperable, and operationally usable across systems. Unfortunately, modern clinical data technology is rarely comprised of a single system or cleanly integrated systems. In fact, the modern clinical data technology environment is highly fragmented. Over the past decade these environments have become significantly more complex, with data flowing in from a growing network of systems, vendors, devices, and external partners. Clinical teams are now managing data not only from EDC systems, but also from imaging vendors, laboratories, wearable devices, eCOA platforms, CTMS applications, safety systems, biomarker data, and an increasing number of structured, semi-structured, and unstructured sources.
As the complexity of the data landscape has increased, the ability to harmonize data and use it for informed decision-making has become a Herculean task. Organizations looking to gain better control of their data have reached the same conclusion: There are simply too many systems, too many vendors, and too many disconnected workflows. The natural response has been to pursue system consolidation.
Unfortunately, when it comes to gaining control of your clinical data, system consolidation may not be the answer. So, what is the real problem organizations are trying to solve, and how do they solve it?
Can System Consolidation Solve Data Complexity?
In trying to solve for efficiency, many organizations view their primary challenge as one of system fragmentation. Single-vendor clinical trial ecosystems offer system consolidation and promise greater standardization, more centralized oversight, streamlined workflows, and fewer operational handoffs. While this approach can offer meaningful advantages, system consolidation does not eliminate the underlying complexity of modern clinical data environments: a lack of data harmonization.
Accessing data and harmonizing data are fundamentally different problems.
Many single-vendor trial ecosystems include components for clinical data management and review. The clinical data element of these ecosystems might include EDC, eCOA, RTSM, and CTMS all living inside one part of the ecosystem. But organizations are also collecting data from myriad other places: imaging, labs, wearable/devices, external partners, and third-party vendors. Teams still need to extract data from these systems, standardize and reconcile it externally, validate it, and then reintegrate it into downstream workflows before it can be used confidently for analytics, reporting, or AI-driven initiatives.
A single-vendor trial ecosystem might solve a “How do we access data” problem, but it doesn’t solve the larger, more important challenge:
How do we harmonize and operationalize all the data that will continue to originate from many different places?
To support operations, analytics, governance, automation, and AI initiatives, organizations need the ability to transform diverse data into trusted, usable, analysis-ready assets. This requires infrastructure capable of working across sources, systems, standards, and vendors. It requires a true clinical data intelligence platform.
4 Key Questions to Use When Evaluating Clinical Data Intelligence Platforms
If the goal is to generate reliable insights from AI and advanced analytics, sponsors and CROs need a single source of truth for data. They may need to rethink how they evaluate clinical data technology. Here is what organizations need to consider:
Can this system ingest and integrate data from diverse sources?
Because modern clinical data environments involve data captured from a growing number of disparate places, organizations need infrastructure capable of onboarding and integrating diverse data sources quickly and efficiently.
Does this system include built-in data transformation capabilities?
Ingestion alone is not enough. Organizations increasingly need the ability to standardize, map, transform, and operationalize data into trusted, analysis-ready assets that can support analytics, reporting, regulatory workflows, and AI initiatives.
Does this system support data governance, lineage, and transparency?
As organizations rely more heavily on automation and AI-supported decision-making, confidence in the underlying data becomes critical. This requires strong governance capabilities, metadata management, validation processes, and traceability across the data lifecycle.
Does this system enable flexibility across systems and vendors?
Even the most comprehensive clinical platforms cannot eliminate the reality that clinical data will continue to originate from multiple systems and places. Organizations increasingly need source-agnostic infrastructure capable of working across systems, standards, and vendors rather than within a single ecosystem alone.
Shifting the Conversation From Consolidation to Harmonization
As AI and advanced analytics become larger strategic priorities, organizations that can successfully harmonize and operationalize data across complex environments will be better positioned to generate reliable insights, improve operational efficiency, and scale future innovation initiatives. Just as importantly, they will be better positioned to reduce the operational burden created by fragmented data workflows.
This is why organizations are beginning to shift the conversation away from system consolidation alone and toward the broader challenge of creating harmonized, interoperable, analysis-ready data. What sponsors and CROs need is a clinical data foundation capable of supporting faster insights, operational agility, and trustworthy AI-driven decision-making across increasingly complex clinical ecosystems.
